Revance Therapeutics | RVNC - UTANG



UTANG Perubahan Tanggal
AbbVie USD 67.5B 67.5B 2025-12
ALKERMES USD 1.58B 1.51B 2026-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Cara Therapeutics USD 0 0 2025-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 42.5B 3.6M 2025-12
J&J USD 47.93B 2.14B 2025-12
Merck USD 49.34B 7.97B 2025-12
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
P&G USD 36.64B 693M 2025-12
Pacira USD 367.66M 4.53M 2026-03
Supernus Pharmaceuticals USD 40.98M 1.23M 2025-12